Bayesian adaptive N‐of‐1 trials for estimating population and individual treatment effects-Reference-Cited by-同舟云学术

Bayesian adaptive N‐of‐1 trials for estimating population and individual treatment effects

Published:2020-09-24 Issue:29 Volume:39 Page:4499-4518
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Senarathne Siththara Gedara J.¹^ORCID,Overstall Antony M.²,McGree James M.¹

Affiliation:

1. School of Mathematical Sciences Queensland University of Technology Brisbane Queensland Australia

2. Southampton Statistical Sciences Research Institute University of Southampton Southampton UK

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8737

Reference42 articles.

1. Users' Guides to the Medical Literature

2. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment

3. The efficacy and cost effectiveness of N‐of‐1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis;Pope JE;J Rheumatol,2004

4. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials

5. An N‐of‐1 trial service in clinical practice: testing the effectiveness of stimulants for attention‐deficit/hyperactivity disorder;Nikles CJ;Pediatrics,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the ability of adaptive designs to capture trends in hard coral cover;Environmetrics;2023-05-08

2. What research methodologies could make a difference in disability?;Developmental Medicine & Child Neurology;2023-04-02

3. Bayes’ Theorem in Neurocritical Care: Principles and Practice;Neurocritical Care;2023-01-12

4. Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial;Trials;2022-04-27

5. Individualized therapy trials: navigating patient care, research goals and ethics;Nature Medicine;2021-10